AMG 757, a half-life extended bispecific T-cell engager (BiTE(R)) immune therapy against DLL3 in SCLC: Phase 1 interim results Meeting Abstract
| Authors: | Borghaei, H.; Boyer, M.; Johnson, M.; Govindan, R.; Rodrigues, L. P. A.; Blackhall, F.; Boosman, R.; Champiat, S.; Hummel, H. D.; Lai, W. V.; Udagawa, H.; Chiang, A.; Dowlati, A.; Hann, C.; Salgia, R.; Vokes, E.; Minocha, M.; Hashemi-Sadraei, N.; Shetty, A.; Smit, M. A. D.; Yang, H.; Owonikoko, T. |
| Abstract Title: | AMG 757, a half-life extended bispecific T-cell engager (BiTE(R)) immune therapy against DLL3 in SCLC: Phase 1 interim results |
| Meeting Title: | 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 8 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Nov 9-14 |
| Meeting Location: | Virtual |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2020-11-01 |
| Start Page: | A219 |
| End Page: | A220 |
| Language: | English |
| ACCESSION: | WOS:000616665300348 |
| DOI: | 10.1136/jitc-2020-SITC2020.0359 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 359 -- Source: Wos |
